Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Prostatic Diseases × Androgen Antagonists × Clear all

Phase

Phase 3 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Urogenital Neoplasms 1 Prostatic Diseases 1 Genital Neoplasms, Male 1 Adenocarcinoma of the Prostate 1

Interventions

olaparib 1 gedatolisib 1 darolutamide 1 Radiotherapy 1 Pluvicto 1 Nivolumab 1 Lutetium-177 1 Lutetium 1 EPI-506 1 Brachytherapy 1 Androgen Antagonists 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03543189 2026-01-29

Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy

H. Lee Moffitt Cancer Center and Research Institute

Phase 1/2 Active not recruiting

Prostatic Diseases, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡